Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Influenza Vaccine market was valued at 5002 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.56% during the forecast period.
This report presents the market size and development trends by detailing the Influenza Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Influenza Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Influenza Vaccine industry and will help you to build a panoramic view of the industrial development.
Influenza Vaccine Market, By Type:
Quadrivalent
Trivalent
High-Dose
Influenza Vaccine Market, By Application:
Pediatrics
Adults
Some of the leading players are as follows:
Novavax
Mitsubishi Tanabe Pharma
GlaxoSmithKline
Sanofi
AstraZeneca
Abbott
CSL
SK Chemicals
Biocryst Pharmaceuticals
F Hoffmann-La Roche Ag
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Influenza Vaccine Market: Technology Type Analysis
-
4.1 Influenza Vaccine Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Influenza Vaccine Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Quadrivalent
4.3.2 Trivalent
4.3.3 High-Dose
5 Influenza Vaccine Market: Product Analysis
-
5.1 Influenza Vaccine Product Market Share Analysis, 2018 & 2026
-
5.2 Influenza Vaccine Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Influenza Vaccine Market: Application Analysis
-
6.1 Influenza Vaccine Application Market Share Analysis, 2018 & 2026
-
6.2 Influenza Vaccine Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pediatrics
6.3.2 Adults
7 Influenza Vaccine Market: Regional Analysis
-
7.1 Influenza Vaccine Regional Market Share Analysis, 2018 & 2026
-
7.2 Influenza Vaccine Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novavax
9.1.1 Novavax Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Mitsubishi Tanabe Pharma
9.2.1 Mitsubishi Tanabe Pharma Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 GlaxoSmithKline
9.3.1 GlaxoSmithKline Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Sanofi
9.4.1 Sanofi Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 AstraZeneca
9.5.1 AstraZeneca Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Abbott
9.6.1 Abbott Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 CSL
9.7.1 CSL Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 SK Chemicals
9.8.1 SK Chemicals Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Biocryst Pharmaceuticals
9.9.1 Biocryst Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 F Hoffmann-La Roche Ag
9.10.1 F Hoffmann-La Roche Ag Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 107 Figures and 132 Tables)
Figure Quadrivalent Influenza Vaccine market, 2015 - 2026 (USD Million)
Figure Trivalent Influenza Vaccine market, 2015 - 2026 (USD Million)
Figure High-Dose Influenza Vaccine market, 2015 - 2026 (USD Million)
Figure Pediatrics market, 2015 - 2026 (USD Million)
Figure Adults market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table North America Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table North America Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table North America Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Canada Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Canada Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Europe Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Europe Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Europe Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Europe Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Germany Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Germany Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table France Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table France Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Italy Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Italy Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Spain Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Spain Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table China Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table China Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Japan Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Japan Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table India Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table India Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table MEA Influenza Vaccine market, by country, 2015 - 2026 (USD Million)
-
Table MEA Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table MEA Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table MEA Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Influenza Vaccine market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Influenza Vaccine market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Influenza Vaccine market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novavax Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CSL Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table SK Chemicals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biocryst Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F Hoffmann-La Roche Ag Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
